We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Nanoneedle Bio-patch Provides Minimally Invasive Drug Delivery

By LabMedica International staff writers
Posted on 20 Nov 2018
Print article
Image: Silicon nanoneedles embedded in a stretchable and translucent elastomer patch that can be worn on the skin to deliver exact doses of drugs directly into cells (Photo courtesy of Purdue University).
Image: Silicon nanoneedles embedded in a stretchable and translucent elastomer patch that can be worn on the skin to deliver exact doses of drugs directly into cells (Photo courtesy of Purdue University).
A flexible bio-patch made from silicon nanoneedles embedded in a thin layer of elastomer was shown to deliver exact doses of biomolecules to cells and tissues while minimizing discomfort to the wearer.

Vertically ordered arrays of silicon nanoneedles – due to their nanoscale dimension and low cytotoxicity – are capable of minimally invasive nanoinjection of biomolecules into living biological systems such as cells and tissues. Nanoneedle bio-patches are usually fabricated on a bulk silicon wafer that is able to withstand the high temperatures and corrosive chemicals employed in standard nanofabrication processes. These rigid, flat, and opaque silicon wafers do not conform favorably with the soft, curvilinear, and optically transparent biological systems for which they are intended.

To improve this situation, investigators at Purdue University (West Lafayette, IN, USA) developed a unique methodology that enabled construction of vertically ordered silicon nanoneedles on a thin layer of elastomer patch that could flexibly and transparently interface with biological systems.

The investigators reported in the November 9, 2018, online edition of the journal Science Advances that this methodology allowed the heterogeneous integration of vertically ordered silicon nanoneedles with a thin layer of elastomer patch, which could provide a certain degree of mechanical flexibility, optical transparency, and cell and tissue compatibility.

"This means that eight or nine silicon nanoneedles can be injected into a single cell without significantly damaging a cell. So we can use these nanoneedles to deliver biomolecules into cells or even tissues with minimal invasiveness," said senior author Dr. Chi Hwan Lee, assistant professor in of biomedical engineering at Purdue University. "This nanoneedle patch is not only flexible but also transparent, and therefore can also allow simultaneous real-time observation of the interaction between cells and nanoneedles."

Related Links:
Purdue University

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Vaginitis Test
Allplex Vaginitis Screening Assay
New
Silver Member
ACTH Assay
ACTH ELISA

Print article

Channels

Molecular Diagnostics

view channel
Image: The experimental blood test accurately indicates severity and predicts potential recovery from spinal cord injury (Photo courtesy of 123RF)

Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury

The National Institutes of Health estimates that 18,000 individuals in the United States sustain spinal cord injuries (SCIs) annually, resulting in a staggering financial burden of over USD 9.... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.